upadacitinib,tocilizumab
abbvie,roche,jw pharma
['upadacitinib']
pts treated with tcz some residual inflammation treated despite clinical remission: unclear if tcz able to prevent vascular damage tc monotherapy after ultra-short gcs seems to be an effective and safe therapy for ga pts without cranial manifestations.
~ dr. carlo
#eular2023 
Consultant Rheumatologist, Apollo hospitals, Indore,India.